YVONNE SADA to Middle Aged
This is a "connection" page, showing publications YVONNE SADA has written about Middle Aged.
Connection Strength
0.220
-
Harnessing digital health to objectively assess cancer-related fatigue: The impact of fatigue on mobility performance. PLoS One. 2021; 16(2):e0246101.
Score: 0.028
-
Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma. J Natl Compr Canc Netw. 2019 02; 17(2):161-168.
Score: 0.024
-
National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer. J Surg Res. 2019 05; 237:41-49.
Score: 0.024
-
Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer. J Surg Res. 2018 06; 226:15-23.
Score: 0.023
-
Validation of Case Finding Algorithms for Hepatocellular Cancer From Administrative Data and Electronic Health Records Using Natural Language Processing. Med Care. 2016 Feb; 54(2):e9-14.
Score: 0.020
-
Primary care and communication in shared cancer care: a qualitative study. Am J Manag Care. 2011 Apr; 17(4):259-65.
Score: 0.014
-
Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer. Sci Rep. 2024 01 31; 14(1):2612.
Score: 0.009
-
A Multi-Institutional Natural Language Processing Pipeline to Extract Performance Status From Electronic Health Records. Cancer Control. 2024 Jan-Dec; 31:10732748241279518.
Score: 0.009
-
Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer. J Surg Oncol. 2021 May; 123(8):1724-1735.
Score: 0.007
-
Cancer-related cognitive impairment and associated factors in a sample of older male oral-digestive cancer survivors. Psychooncology. 2019 07; 28(7):1551-1558.
Score: 0.006
-
Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019 04; 157(4):1682-1693.e1.
Score: 0.006
-
Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
Score: 0.006
-
Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci. 2018 05; 63(5):1173-1181.
Score: 0.006
-
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer. 2018 Jan 01; 124(1):74-83.
Score: 0.005
-
Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer. Ann Surg. 2017 08; 266(2):297-304.
Score: 0.005
-
Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
Score: 0.005
-
Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. Aliment Pharmacol Ther. 2016 Mar; 43(5):621-30.
Score: 0.005
-
Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. J Surg Res. 2016 Feb; 200(2):552-9.
Score: 0.005
-
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):124-31.e1.
Score: 0.005
-
Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol. 2015 Mar; 13(3):594-601.e1.
Score: 0.004
-
Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology. 2013 May; 57(5):1858-68.
Score: 0.004